Adalvo And Gedeon Richter Join Forces On Semaglutide

Deal On Injectable Obesity Treatment Could Pave Way For Broader GLP-1 Partnership

Adalvo and Richter have signed a global co-development deal for semaglutide (Shutterstock)

More from Deals

More from Leadership